<DOC>
	<DOC>NCT01805323</DOC>
	<brief_summary>This retrospective chart review study will describe the history of patients with retinal disease with macular edema to whom OZURDEX速 (dexamethasone intravitreal implant) is administered, and assess treatment patterns and visual outcomes. OZURDEX速 was previously administered according to general clinical practice.</brief_summary>
	<brief_title>A Retrospective Chart Review of OZURDEX速 in Patients With Macular Edema</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Retinal disease involving macular edema Received at least one OZURDEX速 injection</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>